“Olanzapine Versus Typical Neuroleptics for Schizophrenia: Evaluation of Social and Economic Costs”. Farmeconomia. Health Economics and Therapeutic Pathways 7, no. 2 (September 15, 2006): 119–124. Accessed December 29, 2025. https://journals.seedstm.com/index.php/FE/article/view/681.